APEI Q2 Revenue Beats, Raises 2026 Outlook on Enrollment Growth
APEI sits 68% above its 52-week low of $27.741 on elevated volume (1.8× avg).
Summary
APEI delivered a strong Q2 with revenue of $171.7M, edging past the $170.88M consensus, and swung to a net income of $9.8M from a prior-year loss. Adjusted EBITDA jumped 36.8% to $20.7M, driven by 11% growth in the Health+ segment and 4.7% in Military+. Management raised full-year 2026 guidance significantly—revenue now seen at $690M-$698M, net income at $46.5M-$52.5M, and adjusted EBITDA at $96M-$104M. This follows the 8-K filed today confirming the earnings beat and institutional merger completion, adding concrete numbers to the narrative. The raised outlook and enrollment momentum suggest the strategic initiatives, including the new Orlando Health+ campus, are gaining traction. With shares trading at 18x forward earnings versus 22x three months ago, the improved profitability could support further multiple expansion.
At the time of this announcement, APEI was trading at $46.70 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $869.3M. The 52-week trading range was $27.74 to $61.59. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.